Preclinical News and Research

RSS
DLBCLs resistant to chemotherapy can be reprogrammed to respond using azacitidine

DLBCLs resistant to chemotherapy can be reprogrammed to respond using azacitidine

GHI research aims to target breast cancer stem-like cells using immunotherapy

GHI research aims to target breast cancer stem-like cells using immunotherapy

Novel potential biomarker present in CSF reveals signs of dementia decade before

Novel potential biomarker present in CSF reveals signs of dementia decade before

Researchers identify key mechanism behind aggressive prostate cancer

Researchers identify key mechanism behind aggressive prostate cancer

Osteoarthritis research: an interview with Dr Deborah Mason, Cardiff University

Osteoarthritis research: an interview with Dr Deborah Mason, Cardiff University

New test hints 3 sodas daily hurt lifespan, reproduction in mice

New test hints 3 sodas daily hurt lifespan, reproduction in mice

Discovery Transformation Program funds four projects for diabetes research

Discovery Transformation Program funds four projects for diabetes research

Preclinical study reveals pomalidomide shows promising results for treatment of CNS lymphoma

Preclinical study reveals pomalidomide shows promising results for treatment of CNS lymphoma

New research opens door for development of treatments capable of stopping Alzheimer's disease

New research opens door for development of treatments capable of stopping Alzheimer's disease

Cedars-Sinai launches Phase I clinical trial to study tolerability of immunization to treat Alzheimer's disease

Cedars-Sinai launches Phase I clinical trial to study tolerability of immunization to treat Alzheimer's disease

OGF-OGFr axis can be modulated in human triple-negative breast cancer cells to inhibit proliferation

OGF-OGFr axis can be modulated in human triple-negative breast cancer cells to inhibit proliferation

High mobility group (HMG) genes and cancer: an interview with Dr. Linda Resar, Johns Hopkins University School of Medicine

High mobility group (HMG) genes and cancer: an interview with Dr. Linda Resar, Johns Hopkins University School of Medicine

AmpliPhi releases data on phage therapy for treatment of lung infections in Cystic Fibrosis patients

AmpliPhi releases data on phage therapy for treatment of lung infections in Cystic Fibrosis patients

Teplizumab to block type 1 diabetes proves strikingly effective in phase 2 clinical trial

Teplizumab to block type 1 diabetes proves strikingly effective in phase 2 clinical trial

BioLineRx reports positive results from pre-clinical trials with RHB-104 for treatment of thrombocytopenia

BioLineRx reports positive results from pre-clinical trials with RHB-104 for treatment of thrombocytopenia

Compugen, Bayer sign collaboration and license agreement for antibody-based cancer immunotherapies

Compugen, Bayer sign collaboration and license agreement for antibody-based cancer immunotherapies

ImmunoGen reports net loss of $21.9 million in Q4 2013

ImmunoGen reports net loss of $21.9 million in Q4 2013

Scientists prevent cell sleep to reduce chance of tumor recurrence

Scientists prevent cell sleep to reduce chance of tumor recurrence

Trace substance in sugar improves muscle regeneration in mouse model with muscular dystrophy

Trace substance in sugar improves muscle regeneration in mouse model with muscular dystrophy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.